Subretinal fibrosis develops in 40-50% of nAMD eyes after 5 years of anti-VEGF therapy, associated with worse vision
How often does scarring develop in treated macular degeneration eyes?
A systematic review and meta-analysis of 58 studies in anti-VEGF-treated nAMD eyes found subretinal fibrosis developed in approximately 10-1…
Scarring in treated macular degeneration eyes affects 10% to 15% within two years and up to half by five years, causing vision loss averagin…
Retrospective study identifies imaging biomarkers for AMD progression using machine learning models
Can an eye scan predict who will lose central vision from macular degeneration?
A retrospective cohort study of 324 AMD patients developed machine learning models to predict progression from early to late AMD over 3 year…
Eye scans showing pigment changes and drusen deposits can predict which patients with early macular degeneration are most likely to lose cen…
Stanford OCT AMD classification shows excellent intergrader agreement in diagnostic development study
Can a new eye scan system help doctors agree on macular degeneration stages?
A diagnostic classification development study of 108 patients assessed the newly proposed Stanford OCT Based AMD Classification (SOAC).
A new eye scan system helps specialists agree on macular degeneration stages, reducing confusion for patients and creating a shared language…
FDA Approves Byooviz (ranibizumab) for Neovascular AMD, Macular Edema Following RVO, and Myopic CNV
FDA approves a new eye medicine called Byooviz for three conditions that can cause vision loss
The FDA has approved Byooviz, a VEGF inhibitor, for intravitreal injection to treat neovascular age-related macular degeneration, macular ed…
FDA approves Byooviz to treat three eye conditions causing vision loss from leaky blood vessels in the retina.
Intravitreal Anti-VEGF Shows Anatomic and Visual Gains in Irvine-Gass Syndrome Meta-Analysis
Can eye injections help people with Irvine-Gass syndrome see better?
A systematic review and meta-analysis of 343 eyes with Irvine-Gass syndrome found intravitreal anti-VEGF treatment was associated with a mea…
Eye injections for Irvine-Gass syndrome reduced swelling and improved vision in most patients, though doctors still need to prove these trea…
Meta-analysis: Anti-VEGF biosimilars show equivalent efficacy, safety to reference agents in nAMD
Can cheaper eye drugs work as well as expensive ones? A major review says yes for vision loss in older adults
A meta-analysis of 17 RCTs (n=6694) found no clinically meaningful differences in BCVA improvement at 12 weeks (MD=-0.42, p=0.17) or endpoin…
Cheaper eye drug copies work just as well as expensive originals for treating vision loss in older adults, a major review confirms.
Questions about Age-Related Macular Degeneration
How do smoking and aging affect the risk of having both cataracts and Age-Related Macular Degeneration?
Smoking and aging strongly increase the risk of having both cataracts and age-related macular degeneration, with a synergistic effect in people over 75.
Full answer →Can machine learning models predict if my early Age-Related Macular Degeneration will get worse?
Yes, machine learning models can predict progression from early to late AMD with moderate accuracy, using imaging and clinical data.
Full answer →Is there a link between diabetic retinopathy and getting Age-Related Macular Degeneration?
Current research shows no significant link between diabetic retinopathy and age-related macular degeneration, despite both conditions sharing some similar underlying mechanisms.
Full answer →Does having obstructive sleep apnea increase my risk for Age-Related Macular Degeneration?
Yes, obstructive sleep apnea may increase your risk for age-related macular degeneration, especially the neovascular (wet) form, though the evidence is mixed.
Full answer →